GMAB logo

Genmab A/S (GMAB) EBITDA

Annual EBITDA

$865.17 M
-$173.66 M-16.72%

December 31, 2023

Summary

Performance

1-Year Change

-16.72%

3-Year Change

-8.53%

5-Year Change

+221.28%

15-Year Change

+281.98%

GMAB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.89%
GMAB annual EBITDA is higher than 93.89% of companies in Healthcare sector

High & Low

All-time High

$1.04 B
GMAB annual EBITDA is currently -16.72% below its historical high of $1.04 billion

3-Year Low

$664.97 M
GMAB annual EBITDA is currently +30.11% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
GMAB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 8, 2025
GMAB next annual earnings announcement is scheduled for May 8, 2025

OtherGMABprofitabilitymetrics:

Annual Revenue

$2.39 B
GMAB annual revenue is $2.39 billion

Annual Net Income

$631.85 M
GMAB annual net profit is $631.85 million

Annual EBIT

$822.34 M
GMAB annual earnings before interest & taxes is $822.34 million

Annual EPS

$0.96
GMAB annual earnings per share is $0.96

Quarterly EBITDA

$272.49 M
-$37.27 M-12.03%

September 1, 2024

Summary

Performance

3-Month Change

-12.03%

1-Year Change

-32.49%

3-Year Change

+594.67%

5-Year Change

+594.67%

GMAB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

94.24%
GMAB quarterly EBITDA is higher than 94.24% of companies in Healthcare sector

High & Low

All-time High

$670.32 M
GMAB quarterly EBITDA is currently -59.35% below its historical high of $670.32 million

3-Year Low

$39.23 M
GMAB quarterly EBITDA is currently +594.67% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GMAB previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 8, 2025
GMAB next earnings announcement is scheduled for May 8, 2025

OtherGMABprofitabilitymetrics:

Quarterly Revenue

$816.44 M
GMAB quarterly revenue is $816.44 million

Quarterly Net Income

$186.57 M
GMAB quarterly net profit is $186.57 million

Quarterly EBIT

$255.98 M
GMAB quarterly earnings before interest & taxes is $255.98 million

Quarterly EPS

$0.29
GMAB quarterly earnings per share is $0.29

TTM EBITDA

$983.75 M
-$131.15 M-11.76%

September 1, 2024

Summary

Performance

3-Month Change

-11.76%

1-Year Change

+27.19%

3-Year Change

+6.99%

5-Year Change

+6.99%

GMAB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.9%
GMAB TTM EBITDA is higher than 93.9% of companies in Healthcare sector

High & Low

All-time High

$1.23 B
GMAB TTM EBITDA is currently -20.11% below its historical high of $1.23 billion

3-Year Low

$556.33 M
GMAB TTM EBITDA is currently +76.83% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GMAB previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 8, 2025
GMAB next earnings announcement is scheduled for May 8, 2025

OtherGMABprofitabilitymetrics:

TTM Revenue

$2.89 B
GMAB TTM revenue is $2.89 billion

TTM Net Income

$684.26 M
GMAB TTM net profit is $684.26 million

TTM EBIT

$958.87 M
GMAB TTM earnings before interest & taxes is $958.87 million

TTM EPS

$1.05
GMAB TTM earnings per share is $1.05

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$865.17 M
GMAB annual EBITDA is $865.17 million

Annual Net Income

$631.85 M
GMAB annual net profit is $631.85 million

Annual Interest Expense

$3.92 M
GMAB annual interest expense is $3.92 million

Annual Income Tax

$186.56 M
GMAB annual income tax is $186.56 million

Annual D&A

$42.83 M
GMAB annual depreciation & amortization is $42.83 million

GMAB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.7%-32.5%+27.2%
3 y3 years-8.5%+594.7%+7.0%
5 y5 years+221.3%+594.7%+7.0%

GMAB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-16.7%+30.1%-38.6%+594.7%-11.8%+76.8%
5 y5-year-16.7%+92.0%-59.4%+594.7%-20.1%+125.8%
alltimeall time-16.7%+950.4%-59.4%+1072.6%-20.1%+1914.4%

Genmab A/S EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$272.49 M(-12.0%)
$983.75 M(-11.8%)
Jun 2024
-
$309.76 M(+23.4%)
$1.11 B(+5.5%)
Mar 2024
-
$250.97 M(+66.7%)
$1.06 B(+25.1%)
Dec 2023
$865.17 M(-16.7%)
$150.53 M(-62.7%)
$844.63 M(+9.2%)
Sep 2023
-
$403.64 M(+60.7%)
$773.42 M(-4.9%)
Jun 2023
-
$251.24 M(+540.5%)
$813.57 M(-11.5%)
Mar 2023
-
$39.23 M(-50.5%)
$919.52 M(-5.5%)
Dec 2022
$1.04 B(+56.2%)
$79.32 M(-82.1%)
$973.22 M(-5.8%)
Sep 2022
-
$443.79 M(+24.2%)
$1.03 B(+33.2%)
Jun 2022
-
$357.18 M(+284.4%)
$775.44 M(+39.4%)
Mar 2022
-
$92.92 M(-33.2%)
$556.33 M(-19.9%)
Dec 2021
$664.97 M(-29.7%)
$139.05 M(-25.4%)
$694.73 M(+7.8%)
Sep 2021
-
$186.28 M(+34.9%)
$644.43 M(-4.8%)
Jun 2021
-
$138.08 M(-40.3%)
$676.66 M(-44.0%)
Mar 2021
-
$231.33 M(+160.7%)
$1.21 B(+17.4%)
Dec 2020
$945.83 M(+109.9%)
$88.74 M(-59.4%)
$1.03 B(-16.3%)
Sep 2020
-
$218.52 M(-67.4%)
$1.23 B(+10.1%)
Jun 2020
-
$670.32 M(+1175.4%)
$1.12 B(+136.1%)
Mar 2020
-
$52.56 M(-81.9%)
$473.57 M(+8.7%)
Dec 2019
$450.58 M(+67.3%)
$289.97 M(+175.3%)
$435.62 M(+63.5%)
Sep 2019
-
$105.32 M(+309.4%)
$266.46 M(+38.5%)
Jun 2019
-
$25.73 M(+76.1%)
$192.36 M(+2.2%)
Mar 2019
-
$14.61 M(-87.9%)
$188.27 M(-12.8%)
Dec 2018
$269.29 M(+18.9%)
$120.80 M(+287.0%)
$215.84 M(+8.1%)
Sep 2018
-
$31.22 M(+44.3%)
$199.66 M(+12.4%)
Jun 2018
-
$21.64 M(-48.7%)
$177.66 M(-24.5%)
Mar 2018
-
$42.18 M(-59.7%)
$235.34 M(+20.0%)
Dec 2017
$226.50 M(+30.1%)
$104.63 M(+1035.6%)
$196.10 M(-4.5%)
Sep 2017
-
$9.21 M(-88.4%)
$205.25 M(-8.4%)
Jun 2017
-
$79.31 M(+2587.9%)
$224.05 M(+34.8%)
Mar 2017
-
$2.95 M(-97.4%)
$166.26 M(+0.3%)
Dec 2016
$174.11 M(+48.2%)
$113.77 M(+306.1%)
$165.72 M(+49.3%)
Sep 2016
-
$28.02 M(+30.2%)
$111.00 M(+6.5%)
Jun 2016
-
$21.52 M(+791.0%)
$104.23 M(+17.7%)
Mar 2016
-
$2.42 M(-95.9%)
$88.54 M(-21.2%)
DateAnnualQuarterlyTTM
Dec 2015
$117.45 M(+109.9%)
$59.04 M(+177.9%)
$112.32 M(+75.1%)
Sep 2015
-
$21.25 M(+264.1%)
$64.13 M(-5.2%)
Jun 2015
-
$5.84 M(-77.7%)
$67.65 M(+20.8%)
Mar 2015
-
$26.19 M(+141.4%)
$55.99 M(+15.9%)
Dec 2014
$55.96 M(+290.9%)
$10.85 M(-56.2%)
$48.30 M(+1.4%)
Sep 2014
-
$24.77 M(-525.2%)
$47.66 M(+100.9%)
Jun 2014
-
-$5.83 M(-131.5%)
$23.72 M(-10.2%)
Mar 2014
-
$18.50 M(+81.3%)
$26.41 M(+99.7%)
Dec 2013
$14.31 M(-186.1%)
$10.20 M(+1121.9%)
$13.23 M(>+9900.0%)
Sep 2013
-
$835.10 K(-126.7%)
$114.50 K(-102.2%)
Jun 2013
-
-$3.13 M(-158.9%)
-$5.30 M(-38.6%)
Mar 2013
-
$5.32 M(-282.9%)
-$8.62 M(-64.3%)
Dec 2012
-$16.62 M(-53.8%)
-$2.91 M(-36.5%)
-$24.15 M(-2.2%)
Sep 2012
-
-$4.58 M(-29.1%)
-$24.70 M(-18.8%)
Jun 2012
-
-$6.45 M(-36.8%)
-$30.42 M(-15.2%)
Mar 2012
-
-$10.21 M(+195.4%)
-$35.88 M(-1.0%)
Dec 2011
-$36.01 M(+227.5%)
-$3.46 M(-66.5%)
-$36.24 M(+7.6%)
Sep 2011
-
-$10.30 M(-13.5%)
-$33.67 M(-620.8%)
Jun 2011
-
-$11.91 M(+12.7%)
$6.47 M(+93.8%)
Mar 2011
-
-$10.57 M(+1090.9%)
$3.34 M(-127.1%)
Dec 2010
-$11.00 M(-23.8%)
-$887.50 K(-103.0%)
-$12.30 M(-139.8%)
Sep 2010
-
$29.84 M(-298.3%)
$30.92 M(-233.0%)
Jun 2010
-
-$15.04 M(-42.6%)
-$23.25 M(-35.8%)
Mar 2010
-
-$26.21 M(-161.9%)
-$36.22 M(+204.8%)
Dec 2009
-$14.43 M(-85.8%)
$42.33 M(-274.0%)
-$11.89 M(-78.1%)
Sep 2009
-
-$24.33 M(-13.2%)
-$54.22 M(+81.4%)
Jun 2009
-
-$28.02 M(+1398.6%)
-$29.89 M(+1498.6%)
Mar 2009
-
-$1.87 M
-$1.87 M
Dec 2008
-$101.74 M(+74.1%)
-
-
Dec 2007
-$58.43 M(-17.3%)
-
-
Dec 2006
-$70.69 M(+17.4%)
-
-
Dec 2005
-$60.21 M(-167.0%)
-
-
Dec 2004
$89.89 M(+24.4%)
-
-
Dec 2003
$72.24 M(-9.4%)
-
-
Dec 2002
$79.77 M
-
-

FAQ

  • What is Genmab A/S annual EBITDA?
  • What is the all time high annual EBITDA for Genmab A/S?
  • What is Genmab A/S annual EBITDA year-on-year change?
  • What is Genmab A/S quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Genmab A/S?
  • What is Genmab A/S quarterly EBITDA year-on-year change?
  • What is Genmab A/S TTM EBITDA?
  • What is the all time high TTM EBITDA for Genmab A/S?
  • What is Genmab A/S TTM EBITDA year-on-year change?

What is Genmab A/S annual EBITDA?

The current annual EBITDA of GMAB is $865.17 M

What is the all time high annual EBITDA for Genmab A/S?

Genmab A/S all-time high annual EBITDA is $1.04 B

What is Genmab A/S annual EBITDA year-on-year change?

Over the past year, GMAB annual EBITDA has changed by -$173.66 M (-16.72%)

What is Genmab A/S quarterly EBITDA?

The current quarterly EBITDA of GMAB is $272.49 M

What is the all time high quarterly EBITDA for Genmab A/S?

Genmab A/S all-time high quarterly EBITDA is $670.32 M

What is Genmab A/S quarterly EBITDA year-on-year change?

Over the past year, GMAB quarterly EBITDA has changed by -$131.15 M (-32.49%)

What is Genmab A/S TTM EBITDA?

The current TTM EBITDA of GMAB is $983.75 M

What is the all time high TTM EBITDA for Genmab A/S?

Genmab A/S all-time high TTM EBITDA is $1.23 B

What is Genmab A/S TTM EBITDA year-on-year change?

Over the past year, GMAB TTM EBITDA has changed by +$210.33 M (+27.19%)